Global Artificial Intelligence (AI) in the Cancer Market to Surge

CRI Report has released a report titled “Artificial Intelligence in Cancer Market – Analysis of Market Size, Share & Trends for 2020 – 2030 and Forecasts to 2030” which is anticipated to reach USD XXXX billion by 2030. According to a study by CRI Report, the market is anticipated to portray a CAGR of XX.X% between 2020 and 2030. According to the report, the market is estimated to proliferate owing to the increase in the inflow of patient health-related digital data, growing need to minimize healthcare cost, and rising desire for tailored medication. Another important reason that has increased the need to study and identify illnesses in their early stages is the rise in the prevalence of chronic diseases such as cancer. Deep learning technology would make it simple to anticipate illnesses based on past health data. Furthermore, content analytics, Natural Language Processing (NLP) technologies, and Artificial Intelligence (AI) can aid in the patient’s rapid diagnosis.

The market report on global Artificial Intelligence in Cancer market includes in-depth insights as:

• The estimated value of the market was USD XXXX billion in the year 2020.
• Region wise, the market in North America which held the largest market share in the year 2020, emerged as a key market for Artificial Intelligence in Cancer Market.
• Based on Product type, targeted therapy emerged as a key segment in the global Artificial Intelligence in Cancer Market.
• Based on Cancer type, Lung cancer segment emerged as a key segment in the global Artificial Intelligence in Cancer market.
• Key players are likely to focus on product innovations and expansion through merger to retain their positions in developed markets.

“To help end-users overcome the shortage of radiologists, deliver value-based care, early disease detection and diagnosis, and maintain a competitive edge in the market, companies are increasingly focusing on expanding their geographical reach and introducing newer, innovative solutions through various strategies, including partnerships, product launches, and collaborations.”, according to this report

For years, artificial intelligence (AI) has caught society’s interest and generated excitement about its potential to enhance our lives. AI is already a part of our everyday lives, as well as our interactions with media, transportation, and communications. AI applications in healthcare are gaining traction as a way to enhance illness diagnosis, management, and the creation of successful treatments. Given the enormous number of patients diagnosed with cancer and the large quantity of data collected during treatment, AI applications to improve oncologic care are of particular interest. During medical operations, artificial intelligence assists medical practitioners in retrieving information, interpreting pictures, and planning therapy. It also makes healthcare workers’ jobs easier.

Global Artificial Intelligence in Cancer market is segmented by Product Type into Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Phototherapy, Targeted therapy, Gene Therapy, Sonodynamic Therapy. Among these Targeted Therapy is expected to have the highest growth in the forecast period. This can be attributed to the discovery of cancer cells’ molecular targets. Recent developments in cellular technology and gene therapy have improved our understanding of tumor cells and their metabolism at the molecular level, prompting the development of tailored cancer medication treatments.

Key Players in the Market

• Some of the key players operating in the global Artificial Intelligence in Cancer market are Microsoft Corporation, NVIDIA, IBM, Intel , Siemens Healthineers, GE Healthcare, Digital Diagnostics, Xilinx, InformAI, Enlitic, Day Zero, Diagnostics, Aidence, Butterfly Network, Inc., Prognos, Zebra, Medical Vision.

Get Valuable Insights into Global Artificial Intelligence in Cancer Market

In the new report, CRI Report thrives to present an unbiased analysis of the global Artificial Intelligence in Cancer market that covers the historical demand data as well as the forecast figures for the period, i.e., 2020-2030. The study includes compelling insights into growth that is witnessed in the market. The market is segmented by Product Type into Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Phototherapy, Targeted therapy, Gene Therapy, Sonodynamic Therapy. By Cancer type into Breast cancer, Lung cancer, Melanoma cancer, Colorectal cancer, Prostate cancer, Others. By End User into Diagnosis, Therapy, Prognosis, Health Management, Research. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East and Africa.